Keri Losavio

Editor Keri Losavio has been a professional editor and writer in the medical and financial fields for 20 years and joined the Wiley team in February 2014. She has written for and edited newsletters, magazines, personal memoirs, book proposals, dissertations, textbooks and more.

Articles by Keri Losavio

Dr. Wolfe & the National Data Bank for Rheumatic Diseases (NBD)

September 18, 2023 • By Norra MacReady

Frederick Wolfe, MD, who established the National Data Bank for Rheumatic Disease, passed away Sept. 5, 2023, in Wichita, Kans. The rheumatology community mourns his loss.... [Read More]

Rheumatologists Treat Patients While Ukraine Is at War

September 8, 2023 • By Catherine Kolonko

Rheumatologists living in Ukraine press on with their work of treating patients despite the ongoing war that began with a Russian military invasion.... [Read More]

In Memoriam: Rodanthi Kitridou, a Titan of Rheumatology

August 24, 2023 • By Bonita Libman, MD, FACR, FACP

Dr. Rodanthi Kitridou is fondly remembered by a mentee as a trailblazer and role model.... [Read More]

In Memoriam: The Far-Reaching Legacy of Naomi Rothfield, MD, MACR

August 24, 2023 • By Elizabeth Hofheinz, MPH, MEd

A tribute to the life and distinguished career of Naomi Rothfield, MD, MACR.... [Read More]

The Rheumatologist Honored with 2 Awards of Excellence

July 26, 2023 • By Keri Losavio

We are honored to announce that The Rheumatologist has received two Awards of Excellence from APEX 2023 for content published in calendar year 2022: an Award of Excellence in the category of Public Health Concerns—Health & Medical for the editorial supplement to the April issue, COVID-19: What We Know, and an Award of Excellence for… [Read More]

Welcome Home: ACR & ARP Join Forces to Introduce a New Membership Model

June 5, 2023 • By Elizabeth Hofheinz, MPH, MEd

A pilot membership model is empowering members to come home to the ACR/ARP, with a streamlined website, as well as simplified, robust membership options. ... [Read More]

Large Language Models in Medicine

May 17, 2023 • By Jacqueline Jansz, MD, & Peter T. Sadelski, JD

Large language models are a type of AI that allows users to generate new content, drawing from a huge dataset to learn how to mimic “natural language” with many possible beneficial applications for this technology in medicine.... [Read More]

Sarilumab Approved for the Treatment of Adults with Glucocorticoid-Resistant PMR

March 3, 2023 • By Keri Losavio

First described in 1888, polymyalgia rheumatica (PMR) is a chronic inflammatory condition that almost exclusively affects individuals older than 50.1 Until this week, no therapies for PMR had been approved by the U.S. Food & Drug Administration (FDA).2 Tuesday, Sanofi announced sarilumab (Kevzara) has been approved by the U.S. Food & Drug Administration for the… [Read More]

In Memoriam: A Tribute to Dr. Philip Robinson

January 11, 2023 • By The COVID-19 Global Rheumatology Alliance Steering Committee: Jinoos Yazdany, MD, MPH; Zachary S. Wallace, MD, MSc; Paul Sufka, MD; Emily Sirotich, PhD; Pedro Machado, MD, PhD, FRCP; Jean Liew, MD, MS; Jonathan Hausmann, MD; Rebecca Grainger, MB ChB, PhD; Monique Gore-Massy; & Suleman Bhana, MD, FACR

We write to celebrate the life of Philip C. Robinson, MB ChB, PhD, FRACP, a beloved colleague and leader in rheumatology. Phil died in early January after an unexpected and short illness. He is survived by his wife, Helen, and his two young sons. We have witnessed an incredible outpouring of respect and affection for… [Read More]

Please Hear Me: How Effective Provider-Patient Communication Improved My Psoriatic Arthritis

November 29, 2022 • By Ashley Krivohlavek

PHILADELPHIA—“At age 12, I was diagnosed with psoriasis (PsO), followed by a diagnosis of psoriatic arthritis (PsA) at age 30,” said Ashley Krivohlavek of Oklahoma City in a poster presentation at ACR Convergence 2022. “I’m now 38.” Ms. Krivohlavek’s Story In 2020, I had been on an infused biologic for 18 months, but my… [Read More]